BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 29866491)

  • 21. Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.
    Treurnicht FK; Buys A; Tempia S; Seleka M; Cohen AL; Walaza S; Glass AJ; Rossouw I; McAnerney J; Blumberg L; Cohen C; Venter M
    Influenza Other Respir Viruses; 2019 Jan; 13(1):54-63. PubMed ID: 30218485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
    Ivashchenko AA; Jones JC; Shkil DO; Ivanenkov YA; Pascua PNQ; Penaflor MK; Karapetian RN; Govorkova EA; Ivachtchenko AV
    Antiviral Res; 2023 Sep; 217():105701. PubMed ID: 37567255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
    Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
    J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.
    Abed Y; Schibler M; Checkmahomed L; Carbonneau J; Venable MC; Fage C; Giannotti F; Goncalves AR; Kaiser L; Boivin G
    Antivir Ther; 2019; 24(8):581-587. PubMed ID: 32031540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    Tivane A; Daniels R; Nguenha N; Machalele L; Nacoto A; Pale M; Mateonane E; Mavale S; Chilundo J; Muteto D; Salência J; Albati F; Gudo E; Mussá T; McCauley J
    PLoS One; 2018; 13(7):e0201248. PubMed ID: 30048502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
    Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
    Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors.
    Brown SK; Tseng YY; Aziz A; Baz M; Barr IG
    Antiviral Res; 2022 Apr; 200():105280. PubMed ID: 35304163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2017 Sep; 23(9):609-614. PubMed ID: 28655503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors.
    Mohr PG; Williams J; Tashiro M; Streltsov VA; McKimm-Breschkin JL
    Antiviral Res; 2020 Oct; 182():104895. PubMed ID: 32750469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
    Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Kuwahara T; Shimazu Y; Shimomura T; Watanabe S; Odagiri T;
    Euro Surveill; 2016 Jun; 21(24):. PubMed ID: 27336226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
    Fage C; Tu V; Carbonneau J; Abed Y; Boivin G
    Antivir Ther; 2017; 22(8):711-716. PubMed ID: 29082897
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
    J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.
    van der Vries E; Ip DK; Cowling BJ; Zhang JD; Tong X; Wojtowicz K; Schutten M; Boucher CA
    J Infect Dis; 2016 Jan; 213(2):183-90. PubMed ID: 26160744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
    Ikematsu H; Kawai N; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
    Hurt AC; Besselaar TG; Daniels RS; Ermetal B; Fry A; Gubareva L; Huang W; Lackenby A; Lee RT; Lo J; Maurer-Stroh S; Nguyen HT; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Tashiro M; Tilmanis D; Wang D; Zhang W; Meijer A
    Antiviral Res; 2016 Aug; 132():178-85. PubMed ID: 27265623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.
    Tewawong N; Vichiwattana P; Korkong S; Klinfueng S; Suntronwong N; Thongmee T; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(4):e0175655. PubMed ID: 28410396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.